Gluconorm-VG 1 Glimepiride (1mg) + Metformin (500mg) + Voglibose (0.2mg) Tablet SR – Trusted Exporter & Global Supplier from India | GlobMedIndia
Gluconorm-VG 1 Glimepiride (1mg) + Metformin (500mg) + Voglibose (0.2mg) Tablet SR
Gluconorm-VG 1 Tablet SR is a triple-combination antidiabetic medication containing Glimepiride 1mg, Metformin 500mg, and Voglibose 0.2mg. It is widely prescribed for the effective management of Type 2 Diabetes Mellitus in patients requiring comprehensive blood glucose control. This sustained-release formulation helps regulate fasting and post-meal blood sugar levels while improving overall glycemic control.
GlobMedIndia – The Medicine Exporter is a trusted international pharmaceutical supplier providing fast, safe, and secure worldwide doorstep delivery of medicines. We specialize in exporting life-saving and critical care medicines, including anti-cancer drugs, targeted therapies, injectables, and specialty pharmaceuticals across global markets. We ensure authentic, high-quality, and temperature-controlled pharmaceutical delivery directly from India to patients, hospitals, and healthcare providers worldwide.
Contact Details
WhatsApp: +91 9730316395
Phone: +91 9730316395
Email: info@globmedindia.com
Website: https://globmedsindia.com
About Gluconorm-VG 1 Tablet SR
Gluconorm-VG 1 combines three proven antidiabetic medicines to provide enhanced blood sugar management:
Glimepiride 1mg – Stimulates insulin release from the pancreas.
Metformin 500mg – Reduces glucose production in the liver and improves insulin sensitivity.
Voglibose 0.2mg – Delays carbohydrate absorption from the intestine, reducing post-meal glucose spikes.
The sustained-release (SR) formulation provides prolonged therapeutic action and improved patient compliance.
Uses of Gluconorm-VG 1 Tablet SR
Gluconorm-VG 1 is commonly prescribed for:
Type 2 Diabetes Mellitus
Blood sugar management
Postprandial glucose control
Long-term diabetic care
Insulin resistance management
Prevention of diabetes-related complications
Comprehensive glycemic control
Benefits of Gluconorm-VG 1 Tablet SR
Triple-action diabetes management
Effective fasting and post-meal glucose control
Improved insulin utilization
Reduced glucose absorption
Sustained-release formulation for prolonged action
Enhanced patient compliance
Widely recommended for uncontrolled Type 2 diabetes
Why Choose GlobMedIndia for Gluconorm-VG 1 Export?
GlobMedIndia is a leading pharmaceutical exporter, wholesaler, retailer, and supplier of high-quality diabetes medicines from India.
Our Advantages
Genuine pharmaceutical products
Competitive international pricing
Bulk order fulfillment
Worldwide pharmaceutical exports
Temperature-controlled logistics
Secure packaging and delivery
Fast international shipping
Complete export documentation support
Reliable distributor partnerships
International Export Markets
We supply Gluconorm-VG 1 Tablet SR to:
Saudi Arabia
United Arab Emirates
Qatar
Kuwait
Oman
Bahrain
Africa
Europe
Southeast Asia
North America
Trusted Gluconorm-VG 1 tablet exporter from India to Saudi Arabia
Wholesale supplier of Glimepiride Metformin Voglibose tablets in Riyadh
Reliable diabetes medicine exporter to Jeddah hospitals and pharmacies
Gluconorm-VG 1 distributor for healthcare providers in Dammam
Affordable Type 2 diabetes medicines from India to Saudi Arabia
Triple combination diabetes medicine supplier in Mecca and Medina
Pharmaceutical exporter of antidiabetic medicines to Riyadh
Gluconorm-VG 1 bulk supplier for Saudi Arabian distributors
International supplier of sustained-release diabetes tablets
Global exporter of Glimepiride Metformin Voglibose combination medicines
Order Gluconorm-VG 1 Tablet SR from GlobMedIndia
GlobMedIndia is committed to supplying authentic, high-quality pharmaceutical products worldwide. Whether you are a distributor, importer, pharmacy, hospital, healthcare provider, or government procurement agency, we provide dependable pharmaceutical export solutions tailored to your needs.
Contact us today for wholesale inquiries, bulk orders, distributor partnerships, and international pharmaceutical exports.
